NFL Biosciences SAS (PA:ALNFL) — Stock Price

€0.87 EUR
▼ -0.46% today

NFL Biosciences SAS (PA:ALNFL) is currently trading at €0.87 EUR, down 0.46% today. Over the past 52 weeks, shares have ranged between €0.82 and €1.68. This page tracks NFL Biosciences SAS's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see NFL Biosciences SAS stock valuation.

NFL Biosciences SAS (ALNFL) Stock Price Chart — Daily History & Trading Volume

The chart below tracks NFL Biosciences SAS's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

NFL Biosciences SAS Income Statement — Revenue, Profit & Earnings by Year

NFL Biosciences SAS's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €46.00 €200.01K €0.00 €39.00 €3.00
Cost of Revenue €1.55 Million €56.06K €2.24 Million €530.73K €169.36K
Gross Profit €-67.14K €-56.06K €-2.24 Million €-530.73K €-169.36K
Research & Development
SG&A €279.46K €106.37K
Total Operating Expenses €2.72 Million €4.37 Million €668.96K €371.17K €148.67K
Operating Income €-2.79 Million €-4.43 Million €-3.01 Million €-901.87K €-318.03K
EBITDA €-2.65 Million €-4.05 Million €-2.81 Million €-1.08 Million €-271.09K
EBIT €-2.72 Million €-4.11 Million €-2.86 Million €-1.12 Million €-313.05K
Interest Expense €304.00 €6.51K €493.00 €538.00 €4.99K
Income Before Tax €-2.72 Million €-4.11 Million €-2.86 Million €-1.12 Million €-313.04K
Income Tax Expense €-635.41K €-366.39K €-417.83K €-141.27K €-51.54K
Net Income €-2.08 Million €-3.75 Million €-2.44 Million €-978.24K €-266.49K

NFL Biosciences SAS Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes NFL Biosciences SAS's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €3.61 Million €3.97 Million €2.40 Million €3.69 Million €576.64K
Total Current Assets €3.34 Million €3.82 Million €2.26 Million €3.56 Million €467.69K
Cash & Equivalents €165.29K
Short-term Investments €200.00K €191.44K €160.85K €165.29K
Net Receivables €1.06 Million €1.11 Million €742.29K €219.94K €156.16K
Inventory €-1.11 Million
Property, Plant & Equipment €1.99K €0.00
Goodwill €-1.00
Total Liabilities €2.63 Million €3.62 Million €1.55 Million €397.73K €426.61K
Total Current Liabilities €2.63 Million €3.62 Million €1.55 Million €397.73K €426.61K
Long-term Debt €83.26K €7.00 €85.00K
Net Debt €-1.87 Million €-2.28 Million €-970.33K €-2.95 Million €-225.20K
Total Stockholder Equity €976.43K €349.94K €844.00K €3.29 Million €150.03K
Retained Earnings €-2.08 Million €-7.17 Million €-3.42 Million €-978.24K €-261.50K

NFL Biosciences SAS Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how NFL Biosciences SAS generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 202220212020
Operating Cash Flow €104.89K €87.00K €83.91K
Capital Expenditures €0.00 €0.00 €0.00
Free Cash Flow €104.89K €87.00K €83.91K
Investing Cash Flow
Financing Cash Flow
Dividends Paid
Stock-Based Compensation
Depreciation €52.44K €43.50K €41.96K
Change in Cash €-1.99 Million €2.73 Million €83.91K

NFL Biosciences SAS Earnings History — EPS Actual vs. Analyst Estimates

Track NFL Biosciences SAS's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 16, 2025 0.00 0.00
Jun 20, 2023 -0.26 0.00
Oct 26, 2022 -0.20 0.00
Apr 29, 2022 -0.16 0.00
Oct 04, 2021 -0.04 0.00